Evidence map›Paper›PMID 37292374›Full record

ArticleFrontiers in pediatrics2023

Prevalence and associating factors of long COVID in pediatric patients during the Delta and the Omicron variants.

Tananya Lokanuwatsatien, Araya Satdhabudha, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Phakatip Sinlapamongkolkul, Chanapai Chaiyakulsil, Paskorn Sritipsukho, Pichaya Tantiyavarong

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. [RSV versus SARS-CoV-2 in children : Comparison of hospitalised cases].Wiener medizinische Wochenschrift (1946) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tananya LokanuwatsatienDepartment of Pediatrics, Thammasat University Hospital, Thammasat University, Pathum Thani, Thailand.
Araya SatdhabudhaDepartment of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Auchara TangsathapornpongDepartment of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Pornumpa BunjoungmaneeDepartment of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Phakatip SinlapamongkolkulDepartment of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Chanapai ChaiyakulsilDepartment of Pediatrics, Thammasat University Hospital, Thammasat University, Pathum Thani, Thailand.
Paskorn SritipsukhoDepartment of Pediatrics, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Pichaya TantiyavarongDepartment of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Thammasat University · THThammasat University Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The number of pediatric COVID-19 infections is increasing; however, the data on long COVID conditions in children is still limited. Our study aimed to find the prevalence of long COVID in children during the Delta and Omicron waves, as well as associated factors. Methods: A single-center prospective cohort study was conducted. We included 802 RT-PCR-confirmed COVID-19 pediatric patients in the Delta and Omicron periods. Long COVID was defined as having symptoms for ≥3 months after infection. Parents and/or patients were interviewed by phone. Multivariable logistic regression was performed to find associated factors with long COVID. Results: The overall prevalence of long COVID was 30.2%. The Delta period had more prevalence than the Omicron (36.3% vs. 23.9%). Common symptoms for patients 0-3 years' old were loss of appetite, rhinorrhea, and nasal congestion. Conversely, patients 3-18 years' old had hair loss, dyspnea on exertion, rhinorrhea, and nasal congestion. However, there was no significant negative impact on daily life. Most symptoms improved after a 6-month follow-up. Factors associated with long COVID-19 conditions were infection during the Omicron period (adjusted OR: 0.54; 95% CI: 0.39-0.74, Conclusion: Infection during the Omicron wave has a lower prevalence of long COVID. The prognosis is often favorable, and most symptoms gradually become less. However, pediatricians may schedule appointments to surveil long COVID in children with fever or rhinorrhea as an initial symptom.

Indexed as

COVID-19Delta variantlong COVIDOmicron variantSARS-CoV-2

Identifiers

PMID37292374
PMCPMC10244785
OpenAlexW4378072145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.